Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REPLIGEN CORP | Director | Common Stock | 32.3K | $1.17M | $36.29 | Nov 19, 2024 | Direct |
Neuronetics, Inc. | Director | Common Stock | 290K | $232K | $0.80 | Sep 5, 2024 | Direct |
G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct | ||
REPLIGEN CORP | Director | Stock Option (Right to Buy) | 0 | Nov 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Nov 19, 2024 | 2 | $690K | 4 | Nov 20, 2024 | Director |
GTHX | G1 Therapeutics, Inc. | Sep 18, 2024 | 6 | $0 | 4 | Sep 18, 2024 | Director |
STIM | Neuronetics, Inc. | Sep 5, 2024 | 1 | $20K | 4 | Sep 6, 2024 | Director |
STIM | Neuronetics, Inc. | Aug 28, 2024 | 2 | $21.3K | 4 | Aug 30, 2024 | Director |
STIM | Neuronetics, Inc. | Aug 20, 2024 | 1 | $25K | 4 | Aug 21, 2024 | Director |
STIM | Neuronetics, Inc. | Aug 14, 2024 | 1 | $18.9K | 4 | Aug 16, 2024 | Director |
RGEN | REPLIGEN CORP | Aug 1, 2024 | 2 | $181K | 4 | Aug 1, 2024 | Director |
GTHX | G1 Therapeutics, Inc. | Jun 13, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
STIM | Neuronetics, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
GTHX | G1 Therapeutics, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
STIM | Neuronetics, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
RGEN | REPLIGEN CORP | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
GTHX | G1 Therapeutics, Inc. | Jun 23, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
RGEN | REPLIGEN CORP | May 26, 2022 | 2 | $0 | 4 | May 31, 2022 | Director |
STIM | Neuronetics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
GTHX | G1 Therapeutics, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
STIM | Neuronetics, Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
RGEN | REPLIGEN CORP | May 13, 2021 | 2 | $0 | 4 | May 17, 2021 | Director |